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Bacterial nitric oxide reductase is a membrane-integrated enzyme
that catalyzes the reduction of nitric oxide NO to nitrous oxide N2O
based on the following reaction; 2NO+2H++2e−→N2O+H2O. NOR
is involved in bacterial denitriﬁcation (NO3−→NO2−→NO→N2O→N2),
which is a type of anaerobic respiration, in which cyto-toxic NO is
immediately decomposed after its production from nitrite NO2−, a reac-
tion catalyzed by nitrite reductase [1,2]. In addition, some pathogens
utilize NOR to evade destruction by the immune system, as macro-
phages in mammals use NO as a chemical reagent against infectious
agents [3]. In addition to the biological signiﬁcance of this process, it
would be interesting to understand how the N\O bond is cleaved and
how the N\N bond is formed in the enzymatic reaction by NOR from
a chemical point of view. Furthermore, NOR is important in environ-
mental science studies, since the reactant NO is a type of air pollutant
NOx, and the product N2O is not only a greenhouse gas that is more
powerful than carbon dioxide CO2 by 300 times but is also a main con-
tributor to the depletion of the ozone layer [4]. The largest fraction
(~70%) of the N2O emission on earth is the result of the bacterial break-
down of nitrogen oxides. From these points of view, the structure and
function of bacterial NOR should be elucidated at the molecular level.2. Bacterial nitric oxide reductases
Since the ﬁrst evidence for the NOR activity in the cellular mem-
brane was obtained from Alcaligenes faecalis IAM 1015 in 1971 [5],
NOR activities have been reported for Pseudomonas stutzeri, Rhodobacter
sphaeroides IL 106, Halomonas halodenitriﬁcans and Paracoccus denitriﬁ-
cans. Three types of NORs have been reported thus far (Fig. 1) [6–10].
The ﬁrst isolatedNORwas cNORwhich consists of two subunits, namely
NorB and NorC. The NorC subunit contains a heme c with His and Met
residues as axial ligands, and accepts electrons from an external elec-
tron donor (such as cytochrome c551 or blue-copper azurin) [11–16].
The larger subunit of cNOR, NorB, contains three iron (Fe) centers
[17–23], i.e., two b-type hemes and one non-heme Fe (FeB). The low
spin b-type heme (heme b) mediates the transfer of electrons from
heme c in the NorC subunit to the binuclear catalytic center constructed
from another b-type heme (heme b3) and FeB.
A different type of NOR is a single subunit enzyme that contains an
N-terminal extension relative to the NorC subunit of cNOR. This type
of NOR was found in Ralstonia eutropha H16 (a gram-negative soil
bacterium) [24], Pyrobaculum aerophilum (an archaeum) [25], Synecho-
cystis sp. Strain PCC6803 (a cyanobacterium) [26],Neisseria gonorrhoeae
and Neisseria meningitidis [27,28]. These NORs are designated qNORs,
since a quinol moiety acts as an electron donor in place of the soluble
cytochrome c in cNOR. Electron(s) from the quinol are transferred
to the heme b group and subsequently to the same binuclear catalytic
center found in cNOR.While cNOR is found only in denitrifying bacteria,
many of types of qNOR have been reported in non-denitrifying intracel-
lular pathogens such asN. gonorrhoeae. Therefore, the physiological role
Fig. 1. Schematic models of three NOR: cNOR, qNOR and qCuANOR.
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that is produced by the defense system of the host organism [3,6,29].
The third type of NOR is qCuANOR, which can accept electrons
from both cytochrome c and a quinol moiety [30,31]. The unique fea-
ture of qCuANOR is that the smaller subunit of the enzyme contains
two copper atoms (CuA) like cytochrome oxidase and the amino
acid sequence of the N-terminal 15 residues in the small subunit
has a 65% identity to the corresponding portion of the cytochrome
bo3 oxidase subunit II. The larger subunit of qCuANOR contains FeB
and two heme b as is also found in qNOR and NorB of cNOR.
3. Cytochrome c dependent NOR (cNOR)
Of these three NORs, the most extensively studied enzyme is the
cytochrome c dependent NOR, so-called cNOR. The ﬁrst of this class
of cNOR was isolated from P. stutzeri [18]. Since then, several cNORs
from other bacteria have been puriﬁed and characterized by bio-
chemical, molecular biological, spectroscopic and chemical techniques,
in attempts to understand their structural and functional properties
[7,9,19,21,32–39]. In 1994, NOR was classiﬁed as a member of the
heme-cooper oxidase (HCO) super-family of proteins [40,41], on the
basis of the similarity of the amino acid sequence of the NorB subunit
of cNOR to the catalytic subunit of cytochrome oxidases (COX), an
aerobic respiratory enzyme that catalyzes the reduction of O2 (O2+
4H++4e−→2H2O). NOR is currently believed to share a common
ancestor with COX. Regarding themolecular evolution of the respiratory
enzyme, one scenario is that theNO reducing enzymeNOR under anaer-
obic conditions might have been functionally converted into the O2
reducing enzyme COX, presumably through several structuralmodiﬁca-
tions after the emergence of O2 on the earth (about 3 billion years ago)
[40,42]. However, the opposite scenario, in which NOR could have
evolved fromCOX, is also a possibility, based on the pattern of the distri-
bution of COX and NOR [43,44].
Two equivalent protons and electrons are required in the reaction
catalyzed by NOR. The ﬁrst evidence for this was obtained for the
periplasmic consumption of protons during the NO reduction by
cNOR in 1985 [45]. The bioenergetics of succinate-dependent NO res-
piration in membrane vesicles of Rhodobacter capsulatus was studied
using a carotenoid to monitor the membrane potential [14]. Upon
inhibition of the cytochrome bc1 complex with myxothiazole, both
the succinate-dependent NO reduction and the generation of a trans-
membrane potential are abolished, but NOR activity was restored
with ascorbate and the mediator TMPD (N,N,N′,N′-tetramethyl-p-
phenylenediamine), which donates electrons directly to NOR, but a
transmembrane potential was not generated. The result suggested
that NOR is non-electrogenic, that is, electrons and protons utilized in
the catalytic NO reduction are supplied from the same (periplasmic)
side of the membrane. This suggestion was supported by another
experiment, in which no electrochemical gradient was detected during
the reduction of NO by the cNOR reconstituted into liposomes [39,46].Proton uptake from the periplasmic side was proposed, based on
these electrometric and ﬂow ﬂash experiments for cNOR, but was not
established on a structural basis.
When the amino acid sequences of several NORs were compared
with one another and with those of COXs, it was found that 6 speciﬁc
His residues are highly conserved in both NORs and COXs, whereas 5
Glu residues are conserved in NORs, but not in COXs [7,40,41,47–50].
In addition, homology models of the NorB subunit were constructed
using either the amino acid sequence of P. stutzeri (P.s.) cNOR NorB
and the coordinates of P. denitriﬁcans (Pa.d.) cytochrome aa3 oxidase,
or the amino acid sequence of Pa.d. cNOR NorB and the coordinates
of R. sphaeroides cytochrome aa3 oxidase [7,39]. Both models are com-
prised of 12 trans-membrane helices, and the heme b and the binuc-
lear center (heme b3 and FeB) contain 5 His imidazole groups as their
ligands are buried in this helix bundle. In these models, the pathway
for catalytic protons to the binuclear center is initiated with two con-
served Glu residues on the periplasmic face of the enzyme (Glu122
and Glu125 for Pa.d. cNOR), and terminate in the region of Glu198
and Glu267, both of which were predicted to be located in close prox-
imity to the active site [39,49–52].
4. Pseudomonas aeruginosa cNOR
Fukumori and co-workers ﬁrst isolated cNOR from the membrane
fraction of P. aeruginosa (P.a.) that was cultivated under anaerobic
conditions [19]. The NO reduction activity of P.a. cNOR, as measured
by the conventional method using a combination of ascorbate and
PMS (phenazine methosulfate), was found to be 350 μM-NO/min/μM-
enzyme (at [NO]=10 μM), which is comparable to those of other
cNORs, such as the enzymes isolated from P.s. and Pa.d., both of which
have been extensively studied. The amino acid sequence of P.a. cNOR
is highly homologous to those of P.s. and Pa.d. cNORs; the homologies
of 95 and 94% for NorC and NorB of P.s. cNOR, respectively, and 72 and
75% for NorC and NorB of Pa.d. cNOR, respectively. Five conserved Glu
residues are also present in P.a. cNOR. The optical absorption spectra
of P.a. cNOR in the fully oxidized, fully reduced and CO-bound forms
are shown in Fig. 2A. Comparison on the biochemical and spectroscopic
properties suggests that the overall and active site structure of P.a. cNOR
is similar to those of P.s. and Pa.d. cNORs.
In 2010, we determined the crystal structure of P.a. cNOR in the
form of the complex with its monoclonal antibody Fab (Fig. 3) [53].
The antibody Fab interacts with the NorC subunit through electrostatic,
hydrogen bonding and hydrophobic interactions, as illustrated in Fig. 4.
Numerous water molecules mediate the hydrogen-bonding interac-
tions, while direct hydrogen-bonding was observed as follows;
Asn105 (NorC)–Lys31 (Fab light chain) and Arg109 (NorC)–Asp102
(Fab heavy chain)–Thr425 (NorB). Side chains of Trp98, Ala97 and
Phe94 in NorC participate in hydrophobic interactions with the phenyl
group of Phe56 in the light chain of Fab with distance of 3.8–4.0 Å. In
solution, the antibody reversibly inhibits the NO reduction activity of
Fig. 2. Optical absorption spectra of P. aeruginosa cNOR: resting oxidized state (Fe3+);
solid line, dithionite-reduced state (Fe2+); dotted line, and reduced-CO; broken line.
The spectra were obtained from 4 μM cNOR in 50 mM Tris buffer at pH 8.0 containing
0.05% DDM. Fig. 4. Interaction between cNOR and Fab. Residues involved in the interaction are
shown in a stick model. Interactions are mainly through water-mediated hydrogen
bonds. The propionate of heme c is involved in the hydrogen-bonding network. In
addition, hydrophobic residues and polar and charged residues are also involved in
the direct interaction between cNOR and Fab. Light chain and heavy chain of Fab are
shown in orange and yellow, respectively. Subunits NorC and NorB are shown in blue
and green, respectively. The water molecules are shown as small red spheres.
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plex is active in the presence of ascorbate and PMS, which directly do-
nates electrons to the active site. This result indicates that P.a. cNOR
interacts with the antibody in a manner similar to that with proteinous
electron donors. For example, the mutation of Asn105 or Arg109 in
NorC might result in the loss of NO reduction activity via the inhibition
of interactions with the electron donor.Fig. 3. Structure of P. aeruginosa cNOR–Fab complex. Fab recognizes the soluble domain
(periplasmic region) of cNOR.5. Conserved glutamic acids in P. aeruginosa cNOR
As predicted from homology models, the NorB subunit of cNOR
consists of 12 trans-membrane helices, and the heme b and the binuclear
center (heme b3/FeB) are buried in the hydrophobic interior of the trans-
membrane region. Among the 6 well-conserved His residues, His60 and
His349 serve as axial ligands of heme b in the six-coordinate low spin
state, His347 is the ﬁfth ligand of heme b3, and His207, His258, His259
serve as ligands of non-heme FeB, in good agreement with previous
homologymodels. On the other hand, the location and putative function
of the 5 well-conserved Glu residues are not completely consistent with
predictions based on the homology model. Therefore, we mapped the
Glu residues on the structure of the P.a. cNOR NorB subunit in Fig. 5,
and their possible function is discussed, in relation to the catalytic NO
reduction reaction of cNOR, based on the structure.
5.1. Glu211
Glu211 is one of the ligands of FeB, with a distance of 2.0 Å between
FeB and the carboxylate oxygen (O) atom. Three conservedHis imidazoles
(His207, His258, His259) and possibly the oxygen (O) atom of either
water or a hydroxide are also ligands of FeB, eventually forming a
trigonal-bipyramidal coordination structure, as illustrated in Fig. 6.
The bond distances are shown in Fig. 6. The coordination structure is
comparable to those of mononuclear non-heme iron proteins reported
so far, which have 3His, 1Glu (Asp) and a water O, such as FeSOD (Fe-
containing superoxide dismutase) [54,55]. It was reported that the
mutation of the correspondingGlu in Pa.d. cNORdramatically decreased
the enzymatic activity [49], suggesting that it has an important role,
presumably in the catalytic formation of N2O from two NO molecules.
To understand the molecular mechanism of the catalytic N2O for-
mation on the binuclear center of cNOR, we followed the reaction of
the fully reduced P.a. enzyme with NO using rapid mixing freeze-
quenching techniques [19]. The sample produced at 1 ms after the
mixing of the enzyme with NO gave an ESR spectrum, in which
Fig. 5. Stereo diagram showing the position of highly conserved ﬁve Glu residues of NorB subunit. Glu in the transmembrane region (Glu211, Glu215, Glu280) or at the interface
with NorC subunit (Glu135, Glu138) are shown as green stick models. Main chain of NorB and NorC is shown as ribbon and colored in white and blue, respectively. Hydrophilic
channel proposed as a part of proton delivering pathway from periplasmic side is shown as a magenta surface. TM II, III, IV and V are shown in transparent.
Fig. 6. Binuclear center of cNOR. (A) Side view of heme b3. Non-heme iron (FeB) is
coordinated by Glu211, His207, His258, and His259. Residue Glu211 is connected to
another conserved Glu280 by hydrogen bond. His207 and Glu211 in cNOR correspond
to the His and Tyr, respectively, that are connected by a covalent bond in aa3, bo3 and
ba3 oxidases [77–80], so-called A- and B-type COXs. (B) Viewed perpendicular to the
heme b3 plane. Stick model of His207 side chain and ribbon model of TM VI is shown
in transparent.
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mer signal is originated from the ﬁve-coordinated heme b3 Fe(II)–NO
complex [35], and the latter is assigned to the FeB(II)–NO complex
(S=3/2). On the basis of the EPR data, we proposed that two NO
molecules are shared with two irons in the binuclear center, and
that this species might be the reaction intermediate, which is consis-
tent with the trans-mechanism (see Fig. 7). Low redox potential of the
heme b3 iron (60 mV) in Pa.d. cNOR [21], as compared with the other
redox centers (N300 mV), indicates that the heme b3 iron is difﬁcult
to be reduced (Scheme 1). However, a recent study involving the
redox titration in Pa.d. cNOR showed that the presence of an exoge-
nous ligand, CO, results in the elevation of the redox potential of
heme b3 to a range similar to that of the other redox centers [56].
Therefore, the binding of NO to heme b3 iron could facilitate the re-
duction of the heme b3 iron (Scheme 1). In the trans-mechanism,
the electron transfer from both Fe(II) to the two NO ligands, eventu-
ally the Fe(III)–NO− state, would promote N\N bond formation
through a disproportionation-type reaction, and two protons then
would facilitate N\O bond cleavage to produce N2O and H2OFig. 7. Proposed structures of hyponitrite intermediate in trans and cis mechanism.
(A) Trans mechanism. This mechanism is initiated by the binding of two NO molecules
to the heme iron and FeB. The two ferrous-nitrosyl species then promotes N\N bond
formation by an electrophilic attack of one nitrosyl on the other nitrosyl or by a radical
coupling. (B) Cis-FeB mechanism. Two NO molecules bind at the FeB center to form a
dinitrosyl species, leading to the formation of the hyponitrite species at FeB. (C) Cis-
heme b3 mechanism. A heme b3 nitrosyl species was generated before reacting with
a second NO molecule. Free second NO molecule electrophilically attacks heme b3
nitrosyl species to form the proposed reaction intermediate.
Scheme 1. Proposed trans-mechanism. (1→2) The resting oxidized enzyme is reduced. On the basis of the reported redox potentials [21], non-heme FeB is reduced at ﬁrst. (2→3)
Two NOmolecules binds to reduced FeB and ferric heme b3 iron. In addition, one of the FeB ligands, L4 in this case, dissociates from FeB to accommodate the binding of two NO at the
binuclear center. (3→4) Heme b3 iron is reduced, because the binding of NO to heme b3 possibly elevates the redox potential of the heme b3 iron [56]. Formation of the FeB nitrosyl
and the heme b3 nitrosyl causes the two NO ligands to become closer, and facilitates the electrophilic attack of the FeB nitrosyl to the heme b3 nitrosyl (or the radical coupling
reaction of two nitrosyl group). (4→5) Hyponitrate intermediate is formed by the N\N bond formation. (5→6) Protonations of the oxygen atom of the hyponitrite ligand promote
N\O bond cleavage to produce a nitrous oxide and a water molecule.
Fig. 8. Possible proton pathways for NO reduction. There is the hydrogen-bonding net-
work involving one of FeB ligand, Glu211. Glu280 can be bridging Glu211 and a water
molecule, which interacts with another conserved residue Glu215. Ser277 likely inter-
acts with Glu280 and Thr330. Proposed proton pathway starts from Glu57 through
Glu135 and the propionate of heme b3 as indicated by dotted lines. However, there is
an 8 Å gap between the propionate and Thr330. In addition, the distances between
some residues near the active site are longer than the typical distance for a hydrogen
bond.
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the model study reported by Collman and co-workers, in which NO
binds to both heme and non-heme Fe(II) and one N2O molecule is
produced from two equivalents of NO [57]. However, another NOR
model with a NO complex is thermally stable and does not react fur-
ther to give N2O upon the addition of the proton source [58]. In addi-
tion, it is important to bear in mind that the presence of two
paramagnetic Fe(II)–NO species in the single binuclear center can lead
to spin-coupling and the production of an ESR-silent species [59]. By
contrast, two other mechanisms, so-called cis-mechanisms, have been
also proposed, in which two NO molecules bind to either the heme b3
iron or FeB (see Fig. 7). Thomson and co-workers favor the cis-FeBmech-
anism because this model has a vacant heme b3 site, and a rather stable
ferrous heme nitrosyl {FeNO}7 species, a potential “dead-end” product,
is therefore not formed during the turnover [21,60–63]. In the cis-
heme b3 mechanism, the ﬁrst NO molecule binds to heme b3 to form a
{FeNO}7 species which is then electrophilically attacked by the second
NO molecule [64,65]. The mechanism appears to be analogous to that
proposed for fungal P450-type nitric oxide reductase, P450nor [66–
68]. However, in the case of P450nor, the key step is the formation of
the short-lived intermediate {FeNO}8 by a two-electron (H−) reduction
of the ferric heme–NO complex, while the one-electron reduced form
{FeNO}7 of P450nor never reacts with another NO.
Themolecular mechanism of the NOR catalytic reactions, in partic-
ular the coordination and electronic structures of the reaction inter-
mediate, is still controversial, even after our determination of the
structure of cNOR. However, it should be noted that, in any proposal,
two NO molecules must be accommodated in the space at the heme
b3 and FeB binuclear center. An examination of the active site struc-
ture of P.a. cNOR (Fig. 6) indicates that coordination sphere is quite
crowded and highly packed. Therefore, there is no space to accommo-
date two NO molecules, even after the dissociation of the bridging O
ligand. The ﬁnding clearly suggests that some conformational
changes are needed for the formation of the reaction intermediate,
when two NO molecules bind to the binuclear center. One possible
change might be elongation of the Fe–Fe distance. Richardson and
co-workers proposed the bridging of hyponitrite between heme b3
and FeB as a transient state [69]. In this hypothetical structure, theFe–Fe distance would need to be at least 4.4 Å, indicating that the
irons would need to shift by 0.4 Å from their original (fully oxidized
state) positions to create a space sufﬁciently large to accommodate
two NO molecules.
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(His258, His259 or Glu211) from FeB to create a space for accommodat-
ing the second NO molecule to the binuclear center. Non-heme irons
having two His and one Glu/Asp ligands are frequently observed in
nature [70,71], and the reversible association/dissociation of a carboxylate
ligand from cuprous (Cu2+) having 3 His and 1 Glu was also observed in
the crystal structure of quercetin 2,3-dioxygenase [72,73]. By analogy to
the latter case, we propose that the Glu211 carboxylate in cNOR could
function as the shuttle for catalytic protons from Glu280 (vide infra) to
the bound-NO. On the basis of the crystal structure, it appears that
Glu280 is protonated to form a hydrogen-bond with Glu211, which,
because it is a FeB ligand, is deprotonated. The transfer of a catalytic pro-
ton from Glu280 to Glu211 could induce the dissociation of Glu211
from FeB, which is a potential trigger for accommodating the binding
of two NO molecules at the binuclear center (Scheme 1).
5.2. Glu280
The carboxylate of Glu280 interacts with the carboxylate of Glu211,
in which the distance is 2.4 Å, but does not directly interact with FeB.
In addition, Glu280 possibly bridges the hydroxyl group of Ser277 and
a water molecule, the latter of which is located near Ser251 and the
conserved Glu215. Although some of the distances between them are
a somewhat longer than the normal hydrogen-bonding distance
(Fig. 8), a small conformational change such as the rotation of the
side-chain can alter the distances within the range for hydrogen-
bonding interactions. Ser277 interacts with the hydroxyl group of
Thr330 (Fig. 8), both of which are well conserved residues in all NORs.
On the basis of the mutational results of the corresponding residue to
Glu280 (Glu267 in Pa.d. cNOR) [49], it is likely that the network of
Thr330–Ser277–Glu280–Glu211 acts as a delivery pathway for protons
that are utilized in the catalytic NO reduction. The crystallographic
result is consistent with a previous proposal based on homology
models. However, in our P.a. cNOR crystal structure, Thr330 is free
from any other interactions, and a long gap (8 Å) exists between
Thr330 and the heme b3 propionate. On the other hand, a water cluster
is in close proximity to the heme b3 propionate, and forms a hydrophilic
channel with some amino acid side chains (Asp198 (NorB), Lys53Fig. 9. Comparison of K-pathway of cNOR and COX. (A) The hydrogen-bonding network from
(Phe284, Met218, Met 287, Leu222, Phe290, Leu237) in cNOR. (B) K-channel of P. denitriﬁca
dashed line.(NorC), Glu57 (NorC)), leading to the periplasmic side through the
Ca binding site (vide infra). The channel might function as the proton
transfer pathway from the periplasmic side to the heme b3 propionate.
Therefore, if one or two crystallographically invisible water molecules
were to participate in the interaction between Thr330 and the heme
b3 propionate to connect the long gap, the delivery pathway for the
catalytic proton from the periplasmic side to the binuclear center
could be constituted, as has been predicted. To assess this prediction,
a molecular dynamic simulation should be performed.
5.3. Glu215
Glu215 is located at backside of Glu211, but there is no interaction
between them. Glu215 appears to not be directly responsible for the
NO reduction reaction by cNOR, since the mutant with the equivalent
residue in Pa.d. cNOR retained approximately 50% of the activity of
the WT enzyme [49,50]. However, a NOR model study using a myo-
globin heme pocket by Lu and co-workers [74,75] suggested that, in
addition to the FeB-coordinated Glu carboxylate, another Glu is indis-
pensable for the activation of NO by NOR. The Glu215 carboxylate
group could contribute to the electro-negative environment of the
binuclear center of cNOR, and then eventually contribute to the low
redox potential of heme b3 iron (60 mV), which is lower than those
of heme b (345 mV) and heme c (310 mV) in cNOR [21]. In addition,
when the K-channel of COXs for proton transfer [76–78] was com-
pared with the same region of cNOR, it was noted that Glu215 is
located at the terminal position of the “K-channel” (Fig. 9). It is likely
that this residue might reﬂect the ﬁrst step in the evolutionary path-
way for acquiring a proton delivery pathway from the cytoplasm to
the binuclear center in COX.
5.4. Glu135 and Glu138
In Pa.d. cNOR, when the corresponding residue of Glu135 was
substituted with alanine, glutamine and aspartic acid [51], neither
the optical and EPR spectral properties nor the O2 and CO binding
properties were affected in the variants, suggesting that the active
site structure of cNOR is not altered by these mutations. However,cytoplasmic surface (bottom) to binuclear center is blocked by hydrophobic residues
ns cytochrome aa3 oxidase (PDB ID: 3HB3) [81] for delivering protons is shown as cyan
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Gln mutants, while it was retained in the Asp mutant, but with a
signiﬁcant shift in the pKa of the proton donor. On the other hand,
the substitution with Asp or Gln for the corresponding Glu138 residue
in Pa.d. cNOR showed less than 15% of the activity of the WT enzyme.
On the basis of these experimental results, Glu135 and Glu138 have
been proposed to be located at the entry site of the non-electrogenic
proton transfer pathway that delivers catalytic protons from the peri-
plasm to the buried active site in cNORduring catalytic turnover [39,51].
However, in the crystal structure of P.a. cNOR, Glu135 and Glu138
are not located at the protein surface, but are present on the loop that
connects the transmembrane (TM) helices III and IV (Fig. 10). Glu135
serves as the ligand of Ca, together with the Tyr73 (NorC) phenolate
and Gly71 (NorC) main-chain carbonyl. Ca also bridges the two pro-
pionates of hemes b and b3, possibly to stabilize the relative conﬁgu-
ration of these two hemes. The presence of Ca at the same position
was reported for cytochrome cbb3 oxidase in micro-anaerobic respi-
ration, and a Glu residue is one of the ligands [76]. By contrast, in
the aerobic cytochrome oxidases, Ca is replaced with two positively
charged Arg residues [77–80]. Furthermore, Glu135 in cNOR interacts
with a number of water molecules, which are part of the hydrophilic/
water channel that connects the periplasmic side (vide supra). There-
fore, we propose that the primary role of Glu135 would be ligation to
Ca, thereby maintaining the conﬁguration of heme b and b3. In addi-
tion to this, Glu135 could assist in the water-mediated proton trans-
fer through the interactions with a number of water molecules.
On the other hand, Glu138 is neither directly involved in the for-
mation of the hydrophilic/water channel nor in the coordination of
Ca. However, Glu138 is present on the same loop, as Glu135, which
is present in the interface of NorC and NorB. Its carboxylate partici-
pates in some interactions with the residues in TM II (Arg57, Thr61
and Asn62) mediated by water molecules, as illustrated in Fig. 10. It
is highly plausible that Glu138 could be a key residue for maintainingFig. 10. Glu135 and Glu138 at interface of NorB and NorC. They locate on the loop con-
necting two transmembrane helices (TM III and IV). Glu135 serves as the ligand of
calcium ion that bridges the propionates of heme b and heme b3. Glu138 creates the
hydrogen-bonding network with three waters, Arg57, Thr61, Asn62 and Glu135. This
network would be important for the conformation of the calcium ligands and the inter-
action with NorC subunit.the unique conformation of the long loop through interactions with
the residues in TM II, which would stabilize the coordination of
Glu135 to Ca.
From these observations, it is likely that Glu135 and Glu138 are
not directly involved in electron-coupled proton transfer in the NOR
reaction, but, function as structural factors, contributing to the main-
tenance of a protein conformation that is appropriate for the transfer
of electrons from hemes b and b3 and/or the transfer of protons from
the periplasm to the active site. Thus, the mutational results reported
so far can be explained as follows. The neutral Ala and Gln side chain
in the 135 position cannot stabilize the Ca binding and the Ca ion in
cNOR is lost, resulting in a protein conformation that is unsuitable
for an electron-coupled proton transfer in the catalytic NO reduction,
while the negatively charged Asp at position 135 can retain the Ca
binding, but this results in the perturbation of the proton channel,
resulting in a shift in the pKa but without a loss in enzymatic activity.
To clarify the speciﬁc roles of the conserved Glu135 and Glu138 in
NORs, further structural and functional characterization including
the estimation of the Ca content of the conserved Glu variants
would be desirable.
In summary, the crystal structure of P. aeruginosa cNOR provides
us with insights into its structural and functional properties, some
of which have been extensively discussed. With respect to the well-
conserved glutamic acid residues in NOR, three Glu are located near
the catalytic binuclear center, and two are located on the loop that
connects TM III and TM IV. In particular, new insights into the roles
of Glu135 and Glu138 are reported, both of which possibly contribute
to maintaining the proton and electron transfer steps in the NO re-
duction reaction catalyzed by cNOR. Since it is generally believed
that NOR and COX share a common ancestor in the molecular evolu-
tion of respiratory enzymes, it would be possible through detailed
structural comparison between them to discuss how the NO reducing
enzyme could be altered to produce the O2 reducing enzyme, possibly
through structural modiﬁcation.Acknowledgement
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